Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

New neuroleptic agents reported by Ferrer

Dec. 10, 1996

Novo Nordisk claims dopamine D3 receptor ligands for CNS indications

Dec. 9, 1996

New analgesic compounds with novel mechanism of action disclosed by Novo Nordisk

Dec. 6, 1996

New therapeutic approach to neurogenerative disorders

Dec. 4, 1996

JT discloses new compounds for Alzheimer's disease and other CNS disorders

Dec. 4, 1996

New 5-HT1D antagonists from SmithKline Beecham

Dec. 4, 1996

McNeil describes new antipsychotic compounds

Dec. 4, 1996

Avonex progresses toward European approval

Dec. 3, 1996

New hope for muscular dystrophy sufferers

Dec. 3, 1996

Antiepileptic drug from Neurogen licensed to Wyeth-Ayerst

Dec. 2, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...